Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 24.42B |
| Enterprise Value | 23.54B |
| P/E Ratio | 53.02 |
| PEG Ratio | 0.15 |
| Price/Sales Ratio | 17.75 |
| Price/Book Ratio | 16.92 |
| Enterprise/Revenue | 17 |
| Enterprise/EBITDA | 50.54 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.34 |
| Operating Margin | 0.32 |
AD
Management Effectiveness
| Return On Assets | 0.16 |
| Return On Equity | 0.39 |
Income Statement
| Revenue | 812.73M |
| Revenue/Share | 6.2 |
| Gross Profit | 732.85M |
| EBITDA | -191.04M |
| Net Income | -162.95M |
| Diluted EPS | -0.62 |
Balance Sheet
| Total Cash | 2.47B |
| Total Cash/Share | 9.33 |
| Total Debt | 851.71M |
| Total Debt/Equity | 0.5 |
| Current Ratio | 2.5 |
| Book Value Per Share | 6.53 |
Price History
| 52-Week Change | 3.18 |
| 52-Week High | 160 |
| 52-Week Low | 75.1 |
| Moving Average 50 Days | 119.17 |
| Moving Average 200 Days | 103.74 |
Statistics
| Average Volume | 7.15M |
| Shares Outstanding | 264.71M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.03 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
